Psychiatry & Neurology, Neuromuscular Medicine · Houston, TX
NPI
1487034062
Since 2015
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6560 Fannin St Ste 802
Houston, TX, 77030
Phone (713) 441-3780
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
493 services
Medicare patients, 2024
280
Average age 70
Drug cost, 2024
$3.8M
1,504 prescriptions
Company payments, 2025
$35K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley E Anderson was code 99215 (office e&m - established), 155 times for 113 patients. In total Ashley E Anderson billed 493 services in 28 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 155 | 113 | $131.45 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 39 | $61.16 | $4,648 |
| 99214 Office E&M - Established | Office | 53 | 47 | $87.01 | $4,612 |
| 99221 Hospital E&M - Initial | Facility | 42 | 42 | $62.64 | $2,631 |
| 99205 Office E&M - New | Office | 24 | 24 | $164.55 | $3,949 |
| 99421 Office/Outpatient Services | Office | 19 | 17 | $11.40 | $217 |
| 99215 Office E&M - Established | Facility | 15 | 15 | $107.36 | $1,610 |
By year: 2022 $72K for 1,772 services; 2023 $63K for 833 services; 2024 $45K for 493 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashley E Anderson prescribed most often to Medicare patients was Pyridostigmine Bromide, with 152 prescriptions and refills. In total Ashley E Anderson wrote 1,504 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 152 | 344 | 41 | $40K |
| Gabapentin Generic | 135 | 338 | 44 | $4,224 |
| Mycophenolate Mofetil Generic | 100 | 243 | 27 | $13K |
| Pregabalin Generic | 77 | 203 | 30 | $2,579 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 74 | 74 | Under 11 | $563K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 70 | 70 | Under 11 | $353K |
| Duloxetine Hcl Generic | 66 | 158 | 20 | $1,829 |
| Baclofen Generic | 55 | 93 | 15 | $943 |
| Prednisone Generic | 48 | 136 | 20 | $923 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 42 | 42 | Under 11 | $452K |
| Riluzole Generic | 35 | 62 | 11 | $7,865 |
| Solu-Medrol Methylprednisolone Sod Succ/Pf | 32 | 32 | Under 11 | $330 |
| Azathioprine Generic | 32 | 80 | Under 11 | $3,046 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 26 | 26 | Under 11 | $973K |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 26 | 29 | Under 11 | $609 |
Brand drugs: 449 claims; generic drugs: 1,055 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley E Anderson $35K ($35K in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $14K |
| UCB, Inc. UCB.BR | 12 | $11K |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $4,944 |
| Janssen Scientific Affairs, LLC JNJ | 4 | $3,960 |
| Argenx US, Inc. ARGX | 5 | $207 |
| Pfizer Inc. PFE | 8 | $160 |
| Janssen Biotech, Inc. JNJ | 2 | $99.78 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $81.8 |
| CSL Behring CSL.AX | 2 | $75.97 |
| Genentech USA, Inc. ROG.SW | 2 | $46.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.